IMNN Projected Dividend Yield
Com Par $ (New) 2022/Imunon Inc ( NASDAQ : IMNN )Imunon, Inc. is a clinical-stage biotechnology company. Co. is focused on advancing a portfolio of treatments that harness the body's natural mechanisms across an array of human diseases. Co. is developing non-viral Deoxyribonucleic acid (DNA) technology across four modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit a strong immunological response. The third modality, FixPlas, concerns the application of Imunon's DNA technology to produce universal cancer vaccines, also called tumor associated antigen cancer vaccines. 21 YEAR PERFORMANCE RESULTS |
IMNN Dividend History Detail IMNN Dividend News IMNN Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |